Biofrontera AG

Biofrontera AG a biopharmaceutical company engages in the research development and marketing of dermatological products Its products include Ameluz and BFRhodoLED lamp for the treatment of mild and moderate actinic keratoses on the face and scalp field cancerization and fatal squamous cell carcinoma The company also develops RhodoLED XL for the treatment of multiple interspersed lesions Belixos a modern active cosmetic product for irritated and sensitive skin and Xepi for the treatment of antibioticresistant bacteria It offers its products primarily in the United States Europe and Israel The company has a collaboration and partnership agreement with Maruho Co Ltd Biofrontera AG was founded in 1997 and is headquartered in Leverkusen Germany